Wegovy Pill Results: 6.2% in 3 Months, Timeline, vs Shot
New Wegovy pill results from real life: 5,872 adults who were new to weight-loss drugs and stayed on the pill lost 6.2% of their body weight in three months, about 14 pounds on average. That lines up with the 5.5% seen at 12 weeks in Novo Nordisk's trial. In that trial the average loss reached 13.6% at 64 weeks. To make sure the weight you lose is fat and not muscle, Sharpy gives you one protein target and one 20-minute workout a day.
What results can you expect from the Wegovy pill? The newest answer comes from real life, not a trial. On November 14, 2026, Reuters reported that adults who were new to weight-loss drugs and stayed on the Wegovy pill for three months lost 6.2% of their body weight on average. That is close to the 5.5% seen at 12 weeks in Novo Nordisk's main trial. In that trial, the average loss kept growing to 13.6% at 64 weeks.
Below are the new numbers, a timeline, how the pill compares with the shot, and the limits of the data.
New Wegovy pill results: what the real-world data show
The data come from Ro, a telehealth company, and are being presented at the ObesityWeek 2026 meeting in Washington, DC.
| Detail | Real-world result |
|---|---|
| Who was counted | 5,872 adults who had never taken a weight-loss drug |
| When they started | January 5 to February 7, 2026 |
| Follow-up | Three months, staying on the pill the whole time |
| Average weight loss | 6.2% of body weight |
| In pounds | 13.9 lb (6.3 kg), from a starting weight of 227 lb (103 kg) |
| Lost 5% or more | About three in five |
| Lost 10% or more | About one in six |
Martin Holst Lange, Novo Nordisk's chief scientific officer, told Reuters the results broadly matched the 5.5% weight loss at 12 weeks in the company's late-stage trial. That matters. Real-life results often fall short of trial results, because people in trials get more check-ins and support.
Wegovy pill results timeline
The Wegovy pill (semaglutide tablets) does not start at full strength. The FDA label has you step up over 90 days. So the three-month results above cover the step-up period, before most people have spent any time on the top dose.
| Time | Label dose | What the data show |
|---|---|---|
| Days 1 to 30 | 1.5 mg once a day | No published average. This is the starting dose. |
| Days 31 to 60 | 4 mg | No published average |
| Days 61 to 90 | 9 mg | About 5.5% average loss at 12 weeks in the trial. 6.2% at three months in the real-world group. |
| Day 91 and after | 25 mg | Weight loss continues |
| 64 weeks | 25 mg | 13.6% average loss in the OASIS 4 trial, versus 2.2% on placebo |
Our Wegovy pill dosage chart shows each step and the rules for taking the pill on an empty stomach. Your prescriber decides when you move up.
Wegovy pill results at 1 month and on 1.5 mg
Many people search for one-month results. There is no published one-month average in the trial paper, on the label or in the new data. The first 30 days are on 1.5 mg, the lowest dose. If the scale has barely moved after a few weeks, that does not tell you how the next year will go. Bring questions about your pace to your prescriber. Do not change your dose on your own.
Wegovy pill clinical trial results at 64 weeks
The trial behind the FDA approval is called OASIS 4. Adults with obesity or overweight and no diabetes took the 25 mg tablet or a placebo for 64 weeks. Both groups also got diet and activity advice. These responder numbers are from the FDA label.
| Result at 64 weeks | Wegovy pill 25 mg | Placebo |
|---|---|---|
| Lost 5% or more | 76.3% | 31.3% |
| Lost 10% or more | 59.8% | 14.4% |
| Lost 15% or more | 47.0% | 5.5% |
| Lost 20% or more | 27.9% | 3.1% |
The 13.6% average counts everyone who started, including people who quit. Novo Nordisk reported 16.6% for people who stayed on the pill as directed.
Fast weight loss has a cost. Some of what you lose can be muscle, and eating too little protein makes that worse. Sharpy sets one daily protein target from your body weight and gives you one 20-minute strength workout, so more of the loss is fat. Our protein target guide explains the math.
Wegovy pill results vs injection
The pill and the shot contain the same drug, semaglutide. They have not been compared in the same trial, so read this table as two separate studies.
| Wegovy pill 25 mg | Wegovy injection 2.4 mg | |
|---|---|---|
| Trial | OASIS 4 | STEP 1 |
| Length | 64 weeks | 68 weeks |
| Average weight loss | 13.6% | 14.9% |
| Placebo | 2.2% | 2.4% |
| How often | Once a day | Once a week |
Side effects are the same kind. In OASIS 4, stomach and gut problems such as nausea, vomiting, diarrhea and constipation affected 74.0% of people on the pill and 42.2% on placebo. In the trial, 6.9% of people on the pill stopped because of side effects, versus 5.9% on placebo. The pill carries the same boxed warning as the shot about thyroid C-cell tumors. People with a personal or family history of medullary thyroid cancer or MEN 2 should not take it.
What about people who switch? A separate Ro study presented in September 2026 looked at 194 adults who moved from semaglutide or tirzepatide shots to the pill. They lost another 4.1% on average in three months, and about two in five lost 5% or more. Our guide to switching from injection to pill covers the label rules. For the other pill on the market, see Wegovy pill vs Foundayo.
Results beyond the scale: food noise
Novo Nordisk also released survey data from Ro on November 14, 2026. People who started the pill rated their food noise, the constant thoughts about food, on a 1 to 5 scale. Among 6,180 people who answered, the average score fell from 2.8 to 2.1 at three months. And 86.4% of those who answered reported at least one improvement. The most common was clothes fitting better (67.5%), then eating healthier (51.6%). Our food noise guide explains why cravings fade and what to do with the quiet. For the six-month results in Wegovy shot users, read Wegovy food noise.
How much to trust these results
Keep four limits in mind.
- Only people who stayed on the pill were counted. People who quit in the first three months are not in the average. Novo Nordisk says this can skew results.
- There was no comparison group. Real-world studies show links. They cannot prove cause.
- Novo Nordisk's releases on these Ro studies say the data are self-reported, which can be off.
- The full results have not been published in a journal yet. The 6.2% figure comes from Reuters' report on data headed to the conference.
So treat 6.2% as a fair early signal, not a promise. Your own result depends on your dose, your side effects, how you eat and whether you keep taking it.
How to get the most from the Wegovy pill
- Take it the way the label says. Our dosage chart linked above has the steps.
- Eat enough protein, even when you are not hungry.
- Do strength work two or three times a week.
- Track more than weight. Waist, strength and energy tell you what kind of weight is coming off.
- Tell your prescriber about side effects early. Do not skip or split doses on your own.
Cost can decide whether you stay on it long enough to see results. Our Wegovy pill cost guide lists self-pay, insurance and Medicare options.
The bottom line
The first real-world Wegovy pill results look like the trial: about 6% of body weight in three months for people who stay on it, with more to come at the full dose. The trial average reached 13.6% at 64 weeks. The pill does the appetite part. You do the muscle part. Sharpy gives you one protein target, one 20-minute workout and one Shape Score a day to keep you on track.
Sources
- Reuters via Yahoo News, November 14, 2026: Novo's Wegovy pill helps patients lose about 6% of weight in three months, real-world data show
- Novo Nordisk, November 14, 2026: Wegovy was associated with a reduction in food noise according to real-world studies at ObesityWeek 2026
- Novo Nordisk, September 30, 2026: People switching from weight-loss injections to the Wegovy pill lost 4.1% body weight after three months
- FDA label for Wegovy injection and tablets (DailyMed, revised 6/2026)
- Wharton S, et al. Oral semaglutide at a dose of 25 mg in adults with overweight or obesity (OASIS 4). NEJM, 2025 (PubMed)
- Wilding JPH, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). NEJM, 2021 (PubMed)
Questions people ask
What are the Wegovy pill results after 3 months?
In real-world data reported on November 14, 2026, adults who had never taken a weight-loss drug and stayed on the Wegovy pill for three months lost 6.2% of their body weight on average. That was 13.9 pounds from a starting weight of 227 pounds. About three in five lost 5% or more.
How long does it take to see results from the Wegovy pill?
The numbers we have start at three months. By then the average loss was about 5.5% in the trial and 6.2% in the real-world group. The label has you spend those first 90 days stepping up through 1.5 mg, 4 mg and 9 mg before you reach the 25 mg dose, and the biggest results came later, at 64 weeks.
What are Wegovy pill results at 1 month?
No one-month average has been published in the trial paper, the label or the new real-world data. The first 30 days are spent on the 1.5 mg starting dose. Results differ a lot from person to person, so one month is too early to judge.
Are Wegovy pill results as good as the injection?
They look close, but the two were not tested head to head. In the OASIS 4 trial the 25 mg pill led to 13.6% average weight loss at 64 weeks. In the STEP 1 trial the 2.4 mg weekly injection led to 14.9% at 68 weeks.
What did the Wegovy pill clinical trial results show?
In OASIS 4, adults with obesity or overweight and no diabetes lost 13.6% of their weight on average at 64 weeks, counting everyone who started. On the FDA label, 76.3% lost 5% or more and 47.0% lost 15% or more. Novo Nordisk reported 16.6% for people who stayed on the pill as directed.
Do people who switch from the shot to the Wegovy pill keep losing weight?
In a small real-world study of 194 adults who switched from semaglutide or tirzepatide shots to the Wegovy pill, the average loss was another 4.1% in three months. About two in five lost 5% or more. The study had no comparison group, so it cannot prove the pill caused the loss.
Does the Wegovy pill quiet food noise?
In real-world data Novo Nordisk released on November 14, 2026, people who started the pill reported lower food noise scores at three months. The average score fell from 2.8 to 2.1 on a 1 to 5 scale. This was self-reported and had no placebo group.